Form 4: Iradimed Director Hilda Scharen-Guivel Reports Stock Transactions

Director Hilda Scharen-Guivel reports the vesting and conversion of restricted stock units into common stock of Iradimed Corporation.

Summary

• On October 14, 2024, Hilda Scharen-Guivel, a director of Iradimed Corporation, reported the vesting of 1,767 restricted stock units (RSUs) which converted into 1,767 shares of common stock.
• The RSUs were granted on October 14, 2022, under the company's 2014 Equity Incentive Plan and vest in three equal annual installments beginning October 14, 2023.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock transactions by a company insider, and doesn't inherently indicate positive or negative sentiment. It reflects standard compensation practices.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The vesting of RSUs and conversion to common stock increases the number of shares outstanding, which could have a minor dilutive effect on existing shareholders.

Key Dates